Online citations, reference lists, and bibliographies.

Understanding The Pathophysiology Of Cerebral Amyloid Angiopathy

Laura Gatti, Francesca Tinelli, Emma Scelzo, Francesco Arioli, Giuseppe Di Fede, Laura Obici, Leonardo Pantoni, Giorgio Giaccone, Paola Caroppo, Eugenio Agostino Parati, Anna Bersano
Published 2020 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Cerebral amyloid angiopathy (CAA), one of the main types of cerebral small vessel disease, is a major cause of spontaneous intracerebral haemorrhage and an important contributor to cognitive decline in elderly patients. Despite the number of experimental in vitro studies and animal models, the pathophysiology of CAA is still largely unknown. Although several pathogenic mechanisms including an unbalance between production and clearance of amyloid beta (Aβ) protein as well as ‘the prion hypothesis’ have been invoked as possible disease triggers, they do not explain completely the disease pathogenesis. This incomplete disease knowledge limits the implementation of treatments able to prevent or halt the clinical progression. The continuous increase of CAA patients makes imperative the development of suitable experimental in vitro or animal models to identify disease biomarkers and new pharmacological treatments that could be administered in the early disease stages to prevent irreversible changes and disease progression.
This paper references
10.1016/S0197-4580(99)00103-7
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆
Aksam J. Merched (2000)
10.3389/fneur.2019.00966
Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy
Neethu Michael (2019)
β-amyloid in CSF: Biomarker for preclinical amyloid angiopathy
E. S. Van Etten (2017)
10.1038/nn1302
Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis
Martin C. Herzig (2004)
10.1038/373523a0
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
D. Games (1995)
10.1016/S1474-4422(16)30346-5
Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study
Anna M van Opstal (2017)
10.3233/JAD-160345
Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
Yun Zhai (2016)
10.1038/nature15369
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
Z. Jaunmuktane (2015)
10.1046/J.1471-4159.2000.0742209.X
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
Jerry P. Melchor (2008)
10.1212/WNL.0000000000008590
Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy
A. Charidimou (2019)
10.1186/alzrt262
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
Tiffany L. Sudduth (2014)
10.1146/annurev.biochem.66.1.385
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.
James D. Harper (1997)
10.1038/s41586-018-0790-y
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone
Silvia A. Purro (2018)
10.1097/MOL.0000000000000604
HDL from an Alzheimer's disease perspective
Emily B Button (2019)
10.1186/s40035-017-0091-7
The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
Xue-mei Qi (2017)
10.1074/jbc.M110.127738
Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice*
Iliya Lefterov (2010)
10.1093/brain/awx047
Emerging concepts in sporadic cerebral amyloid angiopathy.
A. Charidimou (2017)
10.1016/S0002-9440(10)63355-X
A Synthetic Peptide Blocking the Apolipoprotein E/β-Amyloid Binding Mitigates β-Amyloid Toxicity and Fibril Formation in Vitro and Reduces β-Amyloid Plaques in Transgenic Mice
Marcin Sadowski (2004)
A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
Marcin Sadowski (2004)
Amyloid imaging of Dutch-type hereditary cerabral amyloid angiopathy
A. P. Schultz (2019)
10.1016/j.neurobiolaging.2007.06.005
β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension
Maria Teresa Gentile (2009)
10.1038/s41598-017-08604-8
Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline
Shuguang Liu (2017)
10.1007/978-3-540-37652-1_18
Commentary on “Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice”
Karen Hsiao Ashe (2006)
10.1073/pnas.97.17.9735
Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation.
Kiyoshi Niwa (2000)
10.1016/j.bbadis.2015.10.005
Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
Jérôme Robert (2016)
10.1038/nature11087
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell (2012)
10.1186/s12916-017-0793-9
Translational models for vascular cognitive impairment: a review including larger species
A. Hainsworth (2017)
10.3233/JAD-2011-101401
Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
Jing Yang (2011)
The role of amyloid β clearance in cerebral amyloid angiopathy: More potential therapeutic targets
X. M. Qi (2017)
10.1038/nri3553
The immunobiology of prion diseases
Adriano Aguzzi (2013)
10.1016/j.bbapap.2013.04.011
Surface-bound basement membrane components accelerate amyloid-β peptide nucleation in air-free wells: an in vitro model of cerebral amyloid angiopathy.
K. Hasegawa (2013)
10.1136/jnnp-2013-306485
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
K. Rannikmäe (2013)
10.1038/nm890
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Rashid Deane (2003)
10.1016/BS.PMBTS.2019.08.001
Future horizons in Alzheimer's disease research.
Thomas Wisniewski (2019)
10.1093/brain/awv313
Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Kelly R. Bales (2016)
10.1038/jcbfm.2009.42
P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β
Leon M. Tai (2009)
10.1074/jbc.M312946200
Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor*
Judianne Davis (2004)
10.1523/JNEUROSCI.21-05-01619.2001
Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy
David T Winkler (2001)
10.3389/fnagi.2019.00172
3D Reconstruction of the Neurovascular Unit Reveals Differential Loss of Cholinergic Innervation in the Cortex and Hippocampus of the Adult Mouse Brain
Shereen Nizari (2019)
10.3233/JAD-2010-100462
Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
P. Santa Candela (2010)
10.1111/jnc.14157
Cerebral amyloid angiopathy as a cause of neurodegeneration
Eric E Smith (2018)
10.1159/000334916
Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy
A. J. Carrano (2012)
10.1161/JAHA.118.011288
Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers
Tijn M. Schouten (2019)
10.1186/s13024-017-0201-0
High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture
J. Robert (2017)
10.1212/WNL.50.4.961
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
S. Greenberg (1998)
10.1016/j.neuroscience.2016.01.041
1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1–40 brain-to-blood efflux and peripheral uptake transport
Yong-xin Guo (2016)
10.1136/jnnp-2012-303898
Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis
Kristiina Rannikmäe (2013)
10.1001/archneurol.2010.178
Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP.
Orso Bugiani (2010)
10.1016/S0197-4580(00)82727-X
Charge alterations of E22 enhance the pathogenic properties of the amyloid-β protein
Jerry P. Melchor (2000)
10.1016/j.neuroscience.2009.01.023
Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease
Donna M. Wilcock (2009)
Ponezumab trial study group, Greenberg SM2. Immunotherapy with ponezumab for probable cerebral amyloid angiopathy
C. Leurent (2019)
10.1212/WNL.0000000000006237
Author response: Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis
Andreas Charidimou (2018)
10.1111/j.1601-183X.2007.00380.x
Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
Sushil KumarSingh (2008)
10.1007/s00401-011-0925-9
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Yoko Okamoto (2011)
10.1002/acn3.79
Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
T. Maki (2014)
10.1007/s00401-018-1822-2
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
Z. Jaunmuktane (2018)
10.1111/j.1749-6632.1997.tb48468.x
Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.
Henryk M. Wisniewski (1997)
10.1186/s40478-019-0719-1
Iatrogenic early onset cerebral amyloid angiopathy 30 years after cerebral trauma with neurosurgery: vascular amyloid deposits are made up of both Aβ40 and Aβ42
Giorgio Giaccone (2019)
10.1016/j.neuron.2017.07.030
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Costantino Iadecola (2017)
10.7554/eLife.29595
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels
Jérôme Robert (2017)
10.1161/STROKEAHA.108.533174
Cerebral Amyloid Angiopathy: Progressive Disruption of the Neurovascular Unit
Gregory Joseph Zipfel (2009)
10.1016/J.MVR.2007.10.004
Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease.
Douglas G. Walker (2008)
10.1093/jnen/59.1.29
In Vitro Evidence That β‐Amyloid Peptide 1–40 Diffuses Across the Blood–Brain Barrier and Affects Its Permeability
N. Strazielle (2000)
10.1016/S0014-5793(03)00261-8
Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells.
Sandra M Sacre (2003)
10.1074/jbc.M110.151084
Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease*
Hung-Kai Chen (2010)
10.1186/s40478-018-0511-7
Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
Michael Burwinkel (2018)
10.1186/s13195-019-0497-9
ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
Emily B Button (2019)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
Hisatomi Arima (2010)
10.1016/S1474-4422(11)70148-X
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study
Alessandro Biffi (2011)
10.3389/fnagi.2019.00001
Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain
Roxana Aldea (2019)
10.1161/HYPERTENSIONAHA.114.04139
Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease
D. Cifuentes (2015)
10.1523/JNEUROSCI.4792-03.2004
Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-β Peptide in Mouse Brain
Nobuhisa Iwata (2004)
10.1002/acn3.761
Immunotherapy with ponezumab for probable cerebral amyloid angiopathy
Claire Leurent (2019)
10.3390/cells8060527
Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2α–ATF4 Pathway in Mouse Microglia
Takayuki Inoue (2019)
10.1186/s40478-019-0662-1
Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
Yoshinori Endo (2019)
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage
J Van Horssen
Cerebral vascular accumulation of Dutch-type Aβ42, but not wild-type Aβ42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type
西辻 和親 (2008)
10.1080/713803730
The NADPH oxidase of endothelial cells.
Bernard M. Babior (2000)
10.1038/nrm2873
Prion-like transmission of protein aggregates in neurodegenerative diseases
Patrik Brundin (2010)
10.1074/jbc.M801487200
The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells*
Kaoru Yamada (2008)
10.1186/s12974-017-0885-7
Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages
Rachita K Sumbria (2017)
10.3233/JAD-2010-090700
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights.
Marianna Mazza (2011)
10.1016/j.neurobiolaging.2018.06.004
The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier
Shino Magaki (2018)
10.1080/14737175.2018.1480938
Cerebral amyloid angiopathy: diagnosis and potential therapies
Stewart A Weber (2018)
10.1016/j.cmet.2014.01.003
High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.
Sophie Stukas (2014)
10.1212/WNL.0000000000003486
&bgr;-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy
Ellis S. van Etten (2017)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
A. Biffi (2015)
10.1007/s00401-009-0501-8
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
Tamas Revesz (2009)
10.1007/s00401-006-0115-3
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
John E. Donahue (2006)
Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy
A. M. Hartz (2012)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
10.1016/j.bbadis.2015.08.024
Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy☆
Abby Keable (2016)
10.1074/jbc.M110.217380
Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors*
Jens Brodbeck (2011)
10.1007/978-1-61779-452-0_16
ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro.
H. Qin (2012)
10.1177/0271678X19899377
In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy.
Susanne J. van Veluw (2020)
10.1074/jbc.M110.127829
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease*
Terry L. Lewis (2010)
10.1523/JNEUROSCI.0350-15.2016
Aβ40 Reduces P-Glycoprotein at the Blood–Brain Barrier through the Ubiquitin–Proteasome Pathway
Anika M. S. Hartz (2016)
10.1001/archneurol.2010.297
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.
Christiane Reitz (2010)
White matter perivascular spaces: An MRI marker in pathology-proven cerebral amyloid angiopathy
A Charidimou (2014)
Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.
Martin C. Herzig (2006)
10.1007/s00401-018-1828-9
Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years
Dominique Hervé (2018)
10.1172/JCI10498
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.
Masayoshi Shibata (2000)
10.1016/j.bbapap.2010.01.012
Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Akiyoshi Morinaga (2010)
10.1016/j.neurobiolaging.2017.08.028
Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease
Sofía Fernández-de Retana (2017)
10.1016/j.jns.2017.08.3269
Identification of post-translational modifications of Aβ peptide in platelet membranes from patients with cerebral amyloid angiopathy
Lin Song (2017)
10.1186/s40478-017-0429-5
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
Satoshi Saito (2017)
White matter perivascular spaces: An MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology
A. Charidimou (2014)
LRP-1, and amyloid-beta protein in Alzheimer's disease
J E Donahue (2006)
10.1172/JCI25247
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.
John R Cirrito (2005)
10.1016/S0197-4580(00)82614-7
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons
Jo Van Dorpe (2000)
10.1080/19336896.2017.1334029
Aβ seeds and prions: How close the fit?
Jay B. Rasmussen (2017)
10.1016/j.neurobiolaging.2013.09.015
ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy
A. J. Carrano (2014)
10.1111/j.1750-3639.2010.00375.x
Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme.
J Scott Miners (2010)
10.1111/j.1750-3639.2006.tb00560.x
Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models
Martin C. Herzig (2006)
10.1177/0271678X18822474
Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid
Susan A. Austin (2019)
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer’s disease and hereditary cerebral hemorrhage with amyloidosis
J. Van Horssen (2001)
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathy
T. Revesz (2009)
10.1515/revneuro-2014-0008
Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type
J.A.L.M. Kamp (2014)
10.1073/pnas.1803539115
On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
Xiaoting Yang (2018)
10.4161/pri.27960
Classifying prion and prion-like phenomena
Djamel Harbi (2014)
10.1161/STROKEAHA.117.016990
Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.
Steven M. Greenberg (2018)
10.1016/j.neuron.2012.11.020
Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology
Robert W. Mahley (2012)
10.1002/brb3.595
Interhemispheric characterization of small vessel disease imaging markers after subcortical infarct
M. V. Valdés Hernández (2017)
10.1007/s00401-018-1866-3
Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
D. Mann (2018)
10.1002/ana.22615
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Mathias Jucker (2011)
10.1073/pnas.96.24.14088
Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.
Michael E. Calhoun (1999)
10.1016/S0197-4580(01)00317-7
Substitution at codon 22 reduces clearance of Alzheimer’s amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood
O. R. Monro (2002)
10.1007/s10072-020-04306-8
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project
Anna Bersano (2020)
10.1111/acel.12728
Amyloid‐beta 1‐40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro
Nina Schultz (2018)
10.1038/s41576-018-0011-4
Prions, prionoids and protein misfolding disorders
Claudia Scheckel (2018)
10.1186/s40478-019-0680-z
Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy
Yingjian You (2019)
10.1002/ana.25407
Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura
G. Banerjee (2019)
10.1016/0006-291X(84)91209-9
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
George G. Glenner (1984)
10.1093/gerona/glq026
Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.
Giovanni Zuliani (2010)
10.1089/ars.2011.3895
Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
A. J. Carrano (2011)
10.1161/STR.0b013e3181ec611b
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
L. Morgenstern (2010)
10.1097/NEN.0000000000000230
Detection and Quantification of &bgr;-Amyloid, Pyroglutamyl A&bgr;, and Tau in Aged Canines
F. Schmidt (2015)
10.1016/j.jns.2017.09.025
Meta-analysis methodology in the microbleeds field: The relevance of the clinical question and study quality in choosing the most appropriate model
A. Charidimou (2017)
10.1172/JCI58642
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
R. Deane (2012)
10.3390/ijms20184616
Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer’s Disease
Baruh Polis (2019)
10.1016/j.nbd.2006.05.010
Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
Thomas van Groen (2006)
10.1038/s41598-018-21641-1
Molecular subtypes of Alzheimer’s disease
Giuseppe Di Fede (2018)
10.1007/s12640-015-9589-x
Sex Dimorphism Profile of Alzheimer’s Disease-Type Pathologies in an APP/PS1 Mouse Model
Shu-Sheng Jiao (2015)
10.1016/j.jalz.2015.04.009
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage
Sergi Martínez-Ramírez (2015)
10.1186/s40478-017-0503-z
Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study
Ignazio Cali (2018)
10.1161/STROKEAHA.111.627562
Amyloid-&bgr; Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Anika M. S. Hartz (2012)
10.1002/ana.25560
Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers.
A. Schultz (2019)
10.3171/2016.5.FOCUS15126
Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
D. Bonda (2016)
10.1126/science.1131864
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Melanie Meyer-Luehmann (2006)
10.1002/ana.25562
Early Aβ reduction prevents progression of cerebral amyloid angiopathy.
Juliane Schelle (2019)
10.1111/j.1600-079X.2008.00570.x
Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-beta1-42.
Juefei Zhou (2008)
10.1016/j.jdermsci.2014.01.001
Cilostazol improves lymphatic function by inducing proliferation and stabilization of lymphatic endothelial cells.
Takayuki Kimura (2014)
10.1038/nature13165
Capillary pericytes regulate cerebral blood flow in health and disease
Catherine N. Hall (2014)
10.1016/S0002-9440(10)62993-8
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.
Jianting Miao (2005)
10.1016/j.brainresrev.2003.08.001
Pathogenesis of cerebral amyloid angiopathy
A. A. Rensink (2003)
10.1042/CS20170033
Animal models of cerebral amyloid angiopathy.
L. Jäkel (2017)
10.1007/s004010100414
Heparan sulfate proteoglycan expression in cerebrovascular amyloid β deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains
J. Horssen (2014)
10.1186/s13024-020-00366-8
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
J. Robert (2020)



Semantic Scholar Logo Some data provided by SemanticScholar